Chinese/Japanese: Pharmacokinetic data have shown
That Asians taking ststins have higher serum levels of these
drugs than Caucasians. The FDA has issued caution when treating
Chinese patients with simvastatin doses exceeding 20 mg/day
Administered with niacin.37 This followed the observation
in the Heart Protection Study 2 of increased risk of myopathy
in those taking simvastatin 40 mg administered with
niacin-containing products(>1 g/day).
Rosuvastatin labeling notes higher blood levels in patients of Asian
Heritage (Filipino, Chinese,